Biography
Andrea Burden obtained her Bachelor of Science degree in Psychology and a Master of Arts in Criminology at the University of Toronto.
Following her Master’s program Andrea enrolled in a Master of Science in the faculty of pharmaceutical sciences at the University of Toronto, with focus in pharmacoepidemiology (drug safety and effectiveness). Following 18-months in the MSc program, she transferred to the PhD stream where her research focus was on osteoporosis medication adherence.
In 2014, she received a CIHR fellowship (2015-2017) to conduct her postdoctoral research in the Netherlands, where her focus is on diabetes and bone health and rheumatoid arthritis. Since 2018 she is an Assistant Professor at ETH Zurich where she holds the chair in pharmacoepidemiology at the Institute of Pharmaceutical Sciences.
Andrea has experience analysing some of the world’s most prestigious healthcare databases from Canada, the UK, Denmark and the Netherlands.
Her primary research line examines the safety and effectiveness of medications in chronic disease management, with particular focus on the relationship between metabolic (diabetes and obesity) and musculoskeletal (osteoporosis and rheumatoid arthritis) diseases.
List of 5 Best Publications
Fracture definitions in observational osteoporosis drug effects studies that leverage healthcare administrative (claims) data: a scoping review
https://pubmed.ncbi.nlm.nih.gov/35578134/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Identification of novel off targets of baricitinib and tofacitinib by machine learning with a focus on thrombosis and viral infection
https://pubmed.ncbi.nlm.nih.gov/35551258/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Comment on: Paradoxically protective effect of glucocorticoids on bone mass and fragility fracture in a large cohort: a cross-sectional study
https://pubmed.ncbi.nlm.nih.gov/35531047/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Corrigendum: When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis
https://pubmed.ncbi.nlm.nih.gov/35370960/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Interruptions of biological and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: a descriptive cohort study assessing trends in patient characteristics in Switzerland
https://pubmed.ncbi.nlm.nih.gov/35292498/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Biological Disease-Modifying Antirheumatic Drugs and Osteoporotic Fracture Risk in Patients with Rheumatoid Arthritis: A Danish Cohort Study
https://pubmed.ncbi.nlm.nih.gov/35134369/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Bone fragility in diabetes: novel concepts and clinical implications
https://pubmed.ncbi.nlm.nih.gov/35101185/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Drug Triggers and Clinic of Acute Generalized Exanthematous Pustulosis (AGEP): A Literature Case Series of 297 Patients
https://pubmed.ncbi.nlm.nih.gov/35054090/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis
https://pubmed.ncbi.nlm.nih.gov/34975756/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Fracture Patterns in Type 1 and Type 2 Diabetes Mellitus: A Narrative Review of Recent Literature
https://pubmed.ncbi.nlm.nih.gov/34931295/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Observational cross-sectional case study of toxicities of antifungal drugs
https://pubmed.ncbi.nlm.nih.gov/34896339/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Prediction of sustained biologic and targeted synthetic DMARD-free remission in rheumatoid arthritis patients
https://pubmed.ncbi.nlm.nih.gov/34888435/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7The association between bariatric surgery and cataract: a propensity score-matched cohort study
https://pubmed.ncbi.nlm.nih.gov/34863672/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7The association of bariatric surgery and Dupuytren's disease: a propensity score-matched cohort study
https://pubmed.ncbi.nlm.nih.gov/34851767/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Community Pharmacist-Administered COVID-19 Vaccinations: A Pilot Customer Survey on Satisfaction and Motivation to Get Vaccinated
https://pubmed.ncbi.nlm.nih.gov/34835251/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7External validation of the PAR-Risk Score to assess potentially avoidable hospital readmission risk in internal medicine patients
https://pubmed.ncbi.nlm.nih.gov/34813625/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Increased radiographic progression of distal hand osteoarthritis occurring during biologic DMARD monotherapy for concomitant rheumatoid arthritis
https://pubmed.ncbi.nlm.nih.gov/34702319/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7A Network Analysis of Drug Combinations Associated with Acute Generalized Exanthematous Pustulosis (AGEP)
https://pubmed.ncbi.nlm.nih.gov/34640505/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Clinical Relevance of a 16-Gene Pharmacogenetic Panel Test for Medication Management in a Cohort of 135 Patients
https://pubmed.ncbi.nlm.nih.gov/34361984/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Comparison of Psoriatic Arthritis and Rheumatoid Arthritis Patients across Body Mass Index Categories in Switzerland
https://pubmed.ncbi.nlm.nih.gov/34300360/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Low-dose oral glucocorticoid therapy and risk of osteoporotic fractures in patients with rheumatoid arthritis: a cohort study using the Clinical Practice Research Datalink
https://pubmed.ncbi.nlm.nih.gov/34255815/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Assessment of minor health disorders with decision tree-based triage in community pharmacies
https://pubmed.ncbi.nlm.nih.gov/34244075/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Thiazolidinediones and Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study
https://pubmed.ncbi.nlm.nih.gov/34129693/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Response to: 'Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study' by Gong and Zhang and Lin et al
https://pubmed.ncbi.nlm.nih.gov/34039619/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Cardiovascular Safety Profile of Romosozumab: A Pharmacovigilance Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS)
https://pubmed.ncbi.nlm.nih.gov/33924496/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Determinants of treatment modification before and after implementation of the updated 2015 NICE guideline on type 2 diabetes: A retrospective cohort study
https://pubmed.ncbi.nlm.nih.gov/33894280/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Global adverse events reported for direct-acting antiviral therapies for the treatment of hepatitis C: an analysis of the World Health Organization VigiBase
https://pubmed.ncbi.nlm.nih.gov/33883523/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Primary and secondary non-response: in need of operational definitions in observational studies
https://pubmed.ncbi.nlm.nih.gov/33883161/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Duration of Bisphosphonate Drug Holidays in Osteoporosis Patients: A Narrative Review of the Evidence and Considerations for Decision-Making
https://pubmed.ncbi.nlm.nih.gov/33803095/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Response to: 'Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study'' by Zheng
https://pubmed.ncbi.nlm.nih.gov/33558257/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Renal ischemic adverse drug events related to tranexamic acid in women of child-bearing age: an analysis of pharmacovigilance data
https://pubmed.ncbi.nlm.nih.gov/33341923/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study
https://pubmed.ncbi.nlm.nih.gov/33310727/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Osteoporosis case ascertainment strategies in European and Asian countries: a comparative review
https://pubmed.ncbi.nlm.nih.gov/33305343/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Implementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practice
https://pubmed.ncbi.nlm.nih.gov/33242107/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7National Poison Center Calls Before vs After Availability of High-Dose Acetaminophen (Paracetamol) Tablets in Switzerland
https://pubmed.ncbi.nlm.nih.gov/33112400/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Incidence of Differentiation Syndrome Associated with Treatment Regimens in Acute Myeloid Leukemia: A Systematic Review of the Literature
https://pubmed.ncbi.nlm.nih.gov/33081000/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Community pharmacist-administered seasonal influenza vaccination: a national customer survey
https://pubmed.ncbi.nlm.nih.gov/32999727/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Movement disorders and use of risperidone and methylphenidate: a review of case reports and an analysis of the WHO database in pharmacovigilance
https://pubmed.ncbi.nlm.nih.gov/32621088/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Thromboembolic Safety Reporting of Tofacitinib and Baricitinib: An Analysis of the WHO VigiBase
https://pubmed.ncbi.nlm.nih.gov/32533433/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Medication as a risk factor for hospitalization due to heart failure and shock: a series of case-crossover studies in Swiss claims data
https://pubmed.ncbi.nlm.nih.gov/32270213/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Drug utilization in the Maastricht Study: A comparison with nationwide data
https://pubmed.ncbi.nlm.nih.gov/31895787/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Pharmacoepidemiology and Big Data Analytics: Challenges and Opportunities when Moving towards Precision Medicine
https://pubmed.ncbi.nlm.nih.gov/31883553/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7The Association of Oral Bisphosphonate Use With Mortality Risk Following a Major Osteoporotic Fracture in the United Kingdom: Population-Based Cohort Study
https://pubmed.ncbi.nlm.nih.gov/31839557/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Association between osteoporosis and statins therapy: the story continues
https://pubmed.ncbi.nlm.nih.gov/31744826/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Secular trends in major osteoporotic fractures among 50+ adults in Denmark between 1995 and 2010
https://pubmed.ncbi.nlm.nih.gov/31418061/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Time trends in oral bisphosphonate initiation in Ontario, Canada over 20 years reflect drug policy and healthcare delivery changes
https://pubmed.ncbi.nlm.nih.gov/31317249/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Retraction Note to: Secular trends in major osteoporotic fractures among 50+ adults in Denmark between 1995 and 2010
https://pubmed.ncbi.nlm.nih.gov/31286270/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality
https://pubmed.ncbi.nlm.nih.gov/30264901/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Secular trends in major osteoporotic fractures among 50+ adults in Denmark between 1995 and 2010
https://pubmed.ncbi.nlm.nih.gov/30151659/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7Association between use of antidepressants or benzodiazepines and the risk of subsequent fracture among those aged 65+ in the Netherlands
https://pubmed.ncbi.nlm.nih.gov/30112636/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20220713134318&v=2.17.7